What is Shertech Pharmacy?
Established in 1991, Shertech Pharmacy operates as a sophisticated, independently owned specialty pharmacy provider. The company distinguishes itself through a dual-focus model, offering both nuclear pharmaceuticals and advanced specialty compounding services. By maintaining deep-rooted collaborations with local hospitals and physicians, Shertech Pharmacy integrates itself into the clinical research and medical trial ecosystem. This commitment to life-long learning and evidence-based practice allows the firm to provide highly tailored medical solutions, effectively bridging the gap between complex pharmaceutical manufacturing and patient-centric care. The company's long-standing history serves as a testament to its resilience and adaptability in a highly regulated healthcare environment.
How much funding has Shertech Pharmacy raised?
Shertech Pharmacy has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in Shertech Pharmacy
PPP
Public-Private Partnership
What's next for Shertech Pharmacy?
With the successful closure of this late-stage funding, Shertech Pharmacy is poised to enter a new phase of institutional scaling. The strategic deployment of this capital will likely focus on the expansion of its compounding facilities and the integration of cutting-edge research methodologies into its daily operations. As the company continues to navigate the evolving landscape of specialty medicine, the focus will remain on optimizing supply chain efficiencies and deepening its involvement in clinical trials. This financial backing provides the necessary runway to explore innovative medical techniques, ensuring that Shertech Pharmacy remains at the forefront of pharmaceutical excellence while maintaining its commitment to high-quality, individualized patient outcomes.
See full Shertech Pharmacy company page
